They were designed to treat diabetes, then prescribed for weight loss, and now—as researchers are finding—they might hold the ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts. Today’s piece is by Ana Clara Bobadilla, Colorado State University. (THE CONVERSATION) — ...

Polysubstance abuse, using multiple types of drugs at the same time, is a common cause of death from overdose and an ...

Too often as patients age, doctors pile on prescriptions. The practice, known as polypharmacy, can be dangerous at any age but is particularly hazardous for elderly people, from raising the risk of ...

One lot of reflux medicine got recalled when fluid retention tablets were discovered in the medicine bottles.

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

A UN report found products sold in Singapore as Kpods to contain either etomidate or ketamine. Read more at straitstimes.com.

Navigating 2025 Drug Pricing Policies webinar, panelists discussed the Most Favored Nation executive order, bills aimed at ...

Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...

It has been four days since 27 people overdosed in the Penn North neighborhood, and Baltimore police are still trying to ...

During early drug development and preclinical development, researchers use in vitro cultured lymphocytes to induce cytokine ...